Skip to main content

Clinical Trials

Search among the clinical trials we have open at the Vall d'Hebron Research Institute.

Phase Title Sort descending Service Recruitment
Phase III ' Efficacy and safety of co-administered cagrilintide and… Endocrinology Yes
Phase III : Randomized, Double-Blind, Placebo-Controlled, Multiple Attack Study with… Neurology Yes
Phase II A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center… Psychiatry Yes
Phase II A 52-week randomized,double-blind, placebocontrolled, multi-center… Endocrinology No
Phase III A controlled, open-label post-authorisation efficacy and safety… Nephrology Yes
Phase II A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating… Psychiatry No
Phase II A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled,… Nephrology No
Phase III A Multicenter, Adaptive, Randomized, Controlled Trial Platform To… Infectious No
Phase III A Multicenter, Open-label, Long-term, Safety, Tolerability, andEfficacy Study… Neurology No
Phase III A multi-center, open-label, uncontrolled, single-arm, extension study… Internal Medicine Yes
Phase III A multi-center, randomized, double-blind, placebo controlled,… Cardiology Yes
Phase II A Multicenter, Randomized, Double-Blind, Placebo-Controlled,… Neurology Yes
Phase III A Multi-center, Randomized, Double-blind, Placebo-controlled Trial… General Pediatrics and Specialties Yes
Phase II A Multicentre Controlled Open Randomized Clinical Trial to evaluate… Infectious Yes
Phase III A multicentric, randomized, double-blind, placebo-controlled trial to… Ophthalmology Yes
Phase II A MULTI-PART, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE 2… Internal Medicine Yes
Phase II A novel COMBinATorial therapy with albumin and enoxaparin in patients with… Hepatology Yes
Phase II A parallel-group treatment, proof-of-concept Phase 2, multicenter,… Anesthesia No
Phase I A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-… Neuroimmunology No
Phase II A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter… Rheumatology No
Phase II A phase 2, multicenter, open-label study to assess appropriate dosing… Pediatric Oncohematology Yes
Phase II A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled… Nephrology Yes
Phase II A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the… Nephrology Yes
Phase II A Phase 2 Open-Label Study of Continuation Treatment With Combination… General Pediatrics and Specialties Yes